Molecular Screening Method for Preeclampsia (PREMOM) (PREMOM)
Prospective Clinical Study for the Early Detection of Preeclampsia Based on the Molecular Screening At the First Trimester of Pregnancy
Sponsor: iPremom
A observational or N/A phase clinical study on Preeclampsia, this trial is completed. The trial is conducted by iPremom and has accumulated 10 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Apr 2025 — Sep 2025 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Nov 2024 — Apr 2025 [monthly]
Active Not Recruiting
-
Sep 2024 — Nov 2024 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
▶ Show 5 earlier versions
-
Feb 2024 — Jul 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jun 2023 — Feb 2024 [monthly]
Recruiting
-
Dec 2021 — Jun 2023 [monthly]
Recruiting
-
Nov 2021 — Dec 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Sep 2021 — Nov 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- iPremom
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Albacete, Spain , Alicante, Spain , Barakaldo, Spain , Cartagena, Spain , Castellon, Spain , Córdoba, Spain , Madrid, Spain , Murcia, Spain , Santa Cruz de Tenerife, Spain , Torrejón de Ardoz, Spain and 3 more locations